Approval · Notice of Compliance 8431 · 2006
REACTINE: Notice of Compliance 8431
Issued November 28, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8431
- Date
- November 28, 2006
- Company
- Pfizer Canada Inc., Consumer Healthcare DivisionMarkham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New label claim on 10 mg tablet package
- Therapeutic class
- Histamine h1 receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REACTINE | Not yet assigned | — |
Medicinal ingredients
- CETIRIZINE HYDROCHLORIDE 10 MG per TAB